DermTech Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. DermTech prevailing Real Value cannot be determined due to lack of data. The current price of DermTech is $0.0. Our model computes the value of DermTech from reviewing the firm fundamentals such as Shares Owned By Insiders of 2.62 %, shares outstanding of 34.96 M, and Operating Margin of (5.33) % as well as analyzing its technical indicators and probability of bankruptcy.
DermTech Total Value Analysis
DermTech is currently anticipated to have valuation of 15.43 M with market capitalization of 3.29 M, debt of 54.39 M, and cash on hands of 173.79 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the DermTech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.43 M | 3.29 M | 54.39 M | 173.79 M |
DermTech Investor Information
About 18.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. DermTech recorded a loss per share of 2.65. The entity last dividend was issued on the 30th of August 2019. The firm had 1:2 split on the 30th of August 2019. DermTech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.DermTech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DermTech has an asset utilization ratio of 12.54 percent. This suggests that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that DermTech is more efficient with each dollar of assets it utilizes for everyday operations.DermTech Ownership Allocation
DermTech holds a total of 34.96 Million outstanding shares. Roughly 79.29 percent of DermTech outstanding shares are held by general public with 2.62 (percent) owned by insiders and only 18.09 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.DermTech Profitability Analysis
The company reported the previous year's revenue of 15.3 M. Net Loss for the year was (100.89 M) with profit before overhead, payroll, taxes, and interest of 647 K.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |